Standard BioTools Inc. sold the stake/assets to Illumina, Inc. as part of a M&A on not available.
Deal value was 425000000 (source: Extracted) Sector: Life Sciences; Location: USA.
On the seller side, not available advised, led by Christine Lyon, Damien Zoubek, Jenny Hochenberg, Jenny Leahy, Joe Soltis, Justin Stewart-Teitelbaum, Meghan Rissmiller, Mena Kaplan, Nicole Foster, Sarah Ghulamhussain, Steven Matays, Vinita Kailasanath.
Generated by AI, original source from - Data is in progress
Found it useful? Spread the word.
Freshfields advises Standard BioTools in strategic sale of SomaLogic to Illumina | The Sponsor - The Sponsor
